Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma

Clinical trial NCT01035463 · COMPLETED

Trial details

NCT number: NCT01035463
Sponsor: University of Nebraska
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anaplastic Large Cell Lymphoma, ALK-Negative Recurrent Anaplastic Large Cell Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma Recurrent Non-Hodgkin Lymphoma Recurrent Transformed Non-Hodgkin Lymphoma

Start date: 2009-11-12
Primary completion: 2017-07-27
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.